Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase

Jeanne Montastruc; Philippe Marque; Florence Moulis; Véronique Bourg; Valérie Lambert; Geneviève Durrieu; Jean-Louis Montastruc; François Montastruc

doi:10.1111/dmcn.13286

Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase

Developmental Medicine & Child Neurology ◽

10.1111/dmcn.13286 ◽

2016 ◽

Vol 59 (3) ◽

pp. 329-334 ◽

Cited By ~ 13

Author(s):

Jeanne Montastruc ◽

Philippe Marque ◽

Florence Moulis ◽

Véronique Bourg ◽

Valérie Lambert ◽

...

Keyword(s):

Cerebral Palsy ◽

Epidemiological Study ◽

Adverse Drug Reactions ◽

Botulinum Neurotoxin ◽

Type A ◽

Drug Reactions ◽

Botulinum Neurotoxin Type A ◽

Children With Cerebral Palsy

Download Full-text

Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedules

Journal of Neuroimmunology ◽

10.1016/j.jneuroim.2017.02.014 ◽

2017 ◽

Vol 306 ◽

pp. 31-39 ◽

Cited By ~ 6

Author(s):

Minako Oshima ◽

Philip Deitiker ◽

Tandy Hastings-Ison ◽

K. Roger Aoki ◽

H. Kerr Graham ◽

...

Keyword(s):

Clinical Trial ◽

Cerebral Palsy ◽

Randomized Clinical Trial ◽

Botulinum Neurotoxin ◽

Type A ◽

Antibody Responses ◽

Botulinum Neurotoxin Type A ◽

Children With Cerebral Palsy

Download Full-text

Treatment of cerebral palsy: Use of botulinum neurotoxin type A free of complexing proteins (Xeomin®) in childhood

Neuropediatrics ◽

10.1055/s-0029-1215841 ◽

2008 ◽

Vol 39 (05) ◽

Cited By ~ 1

Author(s):

A Sprinz ◽

M Dercks ◽

J Weglage ◽

A Nagel

Keyword(s):

Cerebral Palsy ◽

Botulinum Neurotoxin ◽

Type A ◽

Botulinum Neurotoxin Type A ◽

Complexing Proteins

Download Full-text

Spread of Botulinum Neurotoxin Type A at Standard Doses Is Inherent to the Successful Treatment of Spastic Equinus Foot in Cerebral Palsy

Journal of Child Neurology ◽

10.1177/0883073811420874 ◽

2011 ◽

Vol 27 (5) ◽

pp. 587-593 ◽

Cited By ~ 9

Author(s):

Emma Frasson ◽

Elisa Dall’Ora ◽

Monia Bordignon ◽

Francesco Brigo ◽

Pierluigi Tocco ◽

...

Keyword(s):

Cerebral Palsy ◽

Successful Treatment ◽

Botulinum Neurotoxin ◽

Type A ◽

Botulinum Neurotoxin Type A

Download Full-text

Hip development in children with cerebral palsy and adductor spasticity treated with botulinum toxin type A: A two-year follow-up

Neuropediatrics ◽

10.1055/s-0029-1215844 ◽

2008 ◽

Vol 39 (05) ◽

Author(s):

NH Jung ◽

F Heinen ◽

A Reissig ◽

B Westhoff ◽

S Berweck ◽

...

Keyword(s):

Cerebral Palsy ◽

Botulinum Toxin ◽

Botulinum Toxin Type A ◽

Type A ◽

Botulinum Toxin Type ◽

Children With Cerebral Palsy

Download Full-text

Faculty Opinions recommendation of In the human urothelium and suburothelium, intradetrusor botulinum neurotoxin type A does not induce apoptosis: preliminary results.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1718956.1228054 ◽

2010 ◽

Author(s):

JLH Ruud Bosch

Keyword(s):

Botulinum Neurotoxin ◽

Type A ◽

Preliminary Results ◽

Botulinum Neurotoxin Type A

Download Full-text

Faculty Opinions recommendation of Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717988167.793477443 ◽

2013 ◽

Author(s):

Patrick McNutt ◽

Ian Gut

Keyword(s):

Neuromuscular Junction ◽

Synaptic Vesicles ◽

Botulinum Neurotoxin ◽

Type A ◽

Botulinum Neurotoxin Type A

Download Full-text

OnabotulinumtoxinA exhibits greater efficacy compared to purified botulinum neurotoxin type A (BoNT/A-150 kDa) in peripheral pain models

Toxicon ◽

10.1016/j.toxicon.2020.11.490 ◽

2021 ◽

Vol 190 ◽

pp. S70

Author(s):

Sudhakar R. Subramaniam ◽

Greg Nicholson ◽

Brian B. Cai ◽

Amy D. Brideau-Andersen ◽

Ron S. Broide

Keyword(s):

Botulinum Neurotoxin ◽

Type A ◽

Botulinum Neurotoxin Type A ◽

Pain Models ◽

Peripheral Pain

Download Full-text

Not only gustatory sweating and flushing: Signs and symptoms associated with Frey's syndrome and the role of botulinum neurotoxin type A therapy

Toxicon ◽

10.1016/j.toxicon.2020.11.437 ◽

2021 ◽

Vol 190 ◽

pp. S46-S47

Author(s):

Maria Raffaella Marchese ◽

Giovanni Almadori

Keyword(s):

Botulinum Neurotoxin ◽

Signs And Symptoms ◽

Type A ◽

Frey’S Syndrome ◽

Botulinum Neurotoxin Type A ◽

Gustatory Sweating ◽

Frey's Syndrome

Download Full-text

Real-world treatment intervals with botulinum neurotoxin type A in poststroke spasticity management—Are different formulations different?

Toxicon ◽

10.1016/j.toxicon.2020.11.475 ◽

2021 ◽

Vol 190 ◽

pp. S63

Author(s):

Susana Rosa ◽

Bruno Guimarães ◽

Joana Martins ◽

José Luís Mesquita ◽

Margarida Freitas ◽

...

Keyword(s):

Real World ◽

Botulinum Neurotoxin ◽

Type A ◽

Botulinum Neurotoxin Type A

Download Full-text

A Review of Tolerance and Safety Profiles of Long-Term Botulinum Neurotoxin Type A in Asian Patients with Hemifacial Spasm and Benign Essential Blepharospasm

Neuro-Ophthalmology ◽

10.1080/01658107.2021.1916043 ◽

2021 ◽

pp. 1-8

Author(s):

Kenneth K. A. Hei Lai ◽

Alan Tsang ◽

Andrew K. T. Kuk ◽

Callie K. L. Ko ◽

Edwin Chan ◽

...

Keyword(s):

Hemifacial Spasm ◽

Botulinum Neurotoxin ◽

Type A ◽

Botulinum Neurotoxin Type A ◽

Asian Patients ◽

Essential Blepharospasm

Download Full-text